USFDA Inspection: Dr Reddy's gets Form 483 with 7 observations for Bollaram facility Farhat Nasim20 Nov 2024 1:48 PM ISTNew Delhi: Dr Reddy's Laboratories Ltd on Tuesday said the US health regulator has issued a Form 483 with seven observations to its active...
Dr Reddy's Hit with Rs 27 Lakh Fine in Mexico Farhat Nasim14 Nov 2024 4:26 PM ISTNew Delhi: Hyderabad-based pharmaceutical giant, Dr Reddy’s Laboratories, has been fined approximately Rs 27 lakh by Mexico’s regulatory body,...
Two Dr Reddy's former employees ordered to repay Rs 41L, Rs 39L VRS amounts for reemployment Farhat Nasim12 Nov 2024 5:16 PM ISTHyderabad: Two former employees of Dr Reddy's Laboratories Limited (Dr Reddys) have been directed by the Labour Court-2 in Hyderabad to repay the VRS...
Dr. Reddy proposal to market antidiabetic FDC of Imeglimin and Vildagliptin rejected by CDSCO Panel Dr. Divya Colin2 Nov 2022 6:00 PM ISTNew Delhi: Noting that the clinical experience with the drug Imeglimin is very limited, the Subject Expert Committee (SEC) functional under the...
Health Bulletin 1/July/2022 Roshni Dhar1 July 2022 5:24 PM ISTHere are the top health stories for the day:National Doctor's Day: Paying tribute to white coat heroesDoctors' Day is observed in the honour of noted...
Dr Reddy's Labs unveils Sorafenib Tablets in US Ruchika Sharma14 Jun 2022 2:42 PM ISTDr Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.
Trademark dispute over anti-ulcer drug Omez: Delhi HC rules in favour of Dr Reddy's Shubhangi Gandhi5 Oct 2021 7:09 PM ISTNew Delhi: In a relief to Dr Reddy's Laboratories, Delhi High Court has accepted an affidavit filed by West-Coast Pharmaceutical Works agreeing...
Dr Reddys fails to secure CDSCO panel nod for Phase 3 trials of Sputnik Light Medical Dialogues Team2 July 2021 2:00 PM ISTNew Delhi: Denying permission to conduct phase-3 trials on the Russian vaccine Sputnik Light in India, the Subject Expert Committee (SEC) functional...
Dr Reddys told to pay around Rs 339 crore to Hatchtech Medical Dialogues Team17 Jun 2021 1:00 PM ISTNew Delhi: Dr Reddy's Laboratories on Tuesday said it has been asked to pay USD 46.25 million (around Rs 339 crore) to Australia-based Hatchtech Pty...
DRDO invites Indian pharma firms for bulk production of COVID drug 2DG Medical Dialogues Team10 Jun 2021 6:26 PM ISTNew Delhi: The Defence Research and Development Organisation (DRDO) has called for an Expression of Interest (EoI) for Transfer of Technology (ToT)...
BMC in talks with Dr Reddys after rejecting all 9 vaccine supply bids Medical Dialogues Team7 Jun 2021 10:15 AM ISTMumbai: After rejecting all nine bids from facilitator firms for procurement of 1 crore Covid-19 vaccine doses for Mumbai due to insufficient...
Dr Reddys out of key antiviral drug Remdesivir stock Medical Dialogues Team19 April 2021 3:06 PM ISTHyderabad: Hyderabad based drugmaker Dr Reddy's Laboratories recently announced that the manufacturer has been running out of stock of the key...
